NFE2L2 and atherosclerosis: Notably, IL-37 has been shown to reduce macrophage ferroptosis by upregulating the nuclear factor erythroid 2-related factor 2 (NRF2) pathway, thereby attenuating the progression of atherosclerosis in murine models [10].